Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase (V.TLT) achieves almost perfect kill rate of cancer cells, Stockhouse poster says

Stockhouse Editorial
1 Comment| July 23, 2015
{{labelSign}}  Favorites
{{errorMessage}}
Top Bullboards post:


“Theralase achieves almost perfect kill-rate of cancer cells,’’ writes IvanVanBeethoven in a Theralase Technologies Inc. (TSX: V.TLT, Stock Forum) post.

Top Bullboard:

Lake Shore Gold Corp. (TSX: T.LSG, Stock Forum) was the most posted bullboard, and received the highest number of reads.

Top blog:


Blogger Rockstone highlights the “Emergence of the most prospective exploration company in the Athabasca Uranium Basin: Lakeland Resources Inc. (TSX: V.LK, Stock Forum).

{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company

JZR Gold Inc.

JZR Gold Inc. V.JZR

JZR Gold Inc. is a Canada-based junior mining resource company. The Company is engaged in the business of the exploration and ... view more »